If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Dec 2020 12:38

RNS Number : 1668K
ADVFN PLC
30 December 2020
 

For immediate release 

30 December 2020

ADVFN PLC

("ADVFN" or the "Company")

Director / PDMR shareholding

 

The Board of ADVFN PLC announces that the Board has agreed to amend the terms of 1,222,946 options held by certain directors, in aggregate representing 4.76 per cent. of the issued share capital of the Company. The exercise price of the options has been re-set at 14p per new ordinary share (compared to a closing mid-market price of 11.5p on 29 December 2020). Prior to the amendment, the options had exercise prices substantially greater than the prevailing market price.

The table below sets out the amended options:

Director

Original grant date

M Hodges

C Chambers

 J Mullins

M Collom

Pre-amendment exercise price per share

Amended exercise price per share

27.01.04

40,000

60,000

40,000

0

118.75p

14p

27.01.05

40,000

60,000

40,000

0

115p

14p

06.09.06

60,000

60,000

60,000

0

82.5p

14p

21.10.09

31,473

31,473

0

0

76.4p

14p

12.12.14

200,000

200,000

100,000

200,000

79.5p

14p

The re-setting of the option exercise price was reviewed by the independent non-executive director of the Company, Mr Tom Spiller and approved on 29 December 2020. Other than an amendment to the exercise price, the terms of the options remain unaltered. Other than the options granted in 2014 (which lapse on 12 December 2024), the options set out in the table above will lapse unless exercised on or before 31 December 2022. No other options have been issued or amended in the prior 12-month period.

A copy of this announcement is available on the Company's website, at www.advfn.com

For further information please contact:

ADVFN PLC

Clem Chambers CEO

Tel: +44 20 3868 6702

 

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish/Michael Cornish

Tel: +44 (0) 207 628 3396

 

Cassiopeia Ltd (Investor Relations)

Stefania Barbaglio

stefania@cassiopeia-ltd.com

 The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Michael Hodges

2. Clem Chambers

3. Jonathan Mullins

4. Matthew Collom

2

 

Reason for the notification

 

a)

 

Position/

status

 

 

1. Chairman

2. Chief Executive

3. Director

4. Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

ADVFN plc

b)

 

LEI

 

21380042SDV1E1ZVIY40

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.2p each ("Ordinary Shares")

Identification code

GB00BPT24C10

 

b)

 

Nature of the transaction

Amendment of exercise price of options over Ordinary Shares

c)

 

Price(s) and volume(s)

Director

Price payable on exercise of option

Volume(s)

 

Michael Hodges

£0.14

371,473

Clem Chambers

£0.14

411,473

Jonathan Mullins

£0.14

240,000

Matthew Collom

£0.14

200,000

d)

 

Aggregated information

- Aggregated volume

1,222,946 options over Ordinary Shares

- Price

Price payable on exercise of option - UK£0.14

e)

 

Date of the transaction

 

29 December 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLBLFXBLLFFBK
Date   Source Headline
4th Apr 202212:25 pmRNSNotice of GM
28th Mar 20228:04 amRNSCorporate Update
22nd Mar 20227:00 amRNSWinners of Financial Awards 2022 Announced
17th Mar 20223:32 pmRNSHolding(s) in Company
17th Mar 20223:32 pmRNSHolding(s) in Company
16th Mar 202210:29 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSCorporate Update
3rd Mar 20225:20 pmRNSCorporate Update
25th Feb 20222:02 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBoard change
23rd Feb 20227:00 amRNSCorporate Update
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 20229:21 amRNSRequisition of general meeting update
8th Feb 202210:54 amRNSStrategic review and end of formal sales process
3rd Feb 202210:47 amRNSForm 8.3 - ADVFN PLC
26th Jan 20221:15 pmRNSRequisition of General Meeting
26th Jan 20227:00 amRNSBest Global Private Investor Multi-Market Informat
24th Jan 20229:35 amRNSForm 8.3 - ADVFN plc
21st Jan 20223:14 pmRNSForm 8.3 - ADVFN plc
19th Jan 20225:03 pmRNSForm 8.3 - ADVFN plc
19th Jan 20224:53 pmRNSForm 8.3 - ADVFN PLC
18th Jan 20227:00 amRNSForm 8 (OPD) ADVFN plc
13th Jan 20227:00 amRNSStrategic review and formal sales process
29th Dec 20215:19 pmRNSHolding(s) in Company
29th Dec 20215:15 pmRNSHolding(s) in Company
23rd Dec 20213:28 pmRNSResult of AGM
22nd Nov 20211:08 pmRNSHolding(s) in Company - Replacement
22nd Nov 202111:00 amRNSPrice Monitoring Extension
22nd Nov 20217:00 amRNSHolding(s) in Company
17th Nov 20217:00 amRNSNominations Open for ADVFN Financial Awards 2022
10th Nov 20218:00 amRNSADVFN Capital Markets Event
10th Nov 20217:00 amRNSFinal Results
12th Oct 20217:00 amRNSWins Cryptocurrency Platform Provider of the Year
14th Sep 20217:00 amRNSSmart Investing Webinars for Robinhood Generation
27th Aug 20211:11 pmRNSInvestor Webinar to Update on Recent Developments
15th Jul 20217:00 amRNSCEO to answer questions at prime investor event
5th Jul 202112:00 pmRNSTrading update and proposed dividend policy
28th May 202111:05 amRNSSecond Price Monitoring Extn
28th May 202111:00 amRNSPrice Monitoring Extension
28th May 20219:05 amRNSSecond Price Monitoring Extn
28th May 20219:00 amRNSPrice Monitoring Extension
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:35 pmRNSPrice Monitoring Extension
27th May 20212:05 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
10th May 20217:00 amRNSCorporate update
4th May 202111:49 amRNSHolding(s) in Company
4th May 202111:47 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20219:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.